Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Dermatology | Monthly Briefing

Back to Journal Articles

October 2012 Briefing - Dermatology

Last Updated: November 01, 2012.

 

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for October 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

U.S. Medicare Spending on Elderly Has Outpaced Canada's

TUESDAY, Oct. 30 (HealthDay News) -- U.S. Medicare spending on the elderly has grown nearly three times faster than its Canadian counterpart, according to a study published online Oct. 29 in the Archives of Internal Medicine.

Full Text (subscription or payment may be required)

Negative Pigment Network Able to Distinguish Melanoma

THURSDAY, Oct. 25 (HealthDay News) -- Negative pigment network (NPN) can be used to distinguish melanoma from Spitz nevus and other benign lesions, according to a study published online Oct. 11 in the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Safety, Efficacy of At-Home Laser for Periobital Wrinkles Studied

WEDNESDAY, Oct. 24 (HealthDay News) -- A handheld nonablative fractional laser is safe and seems effective for home use for treating periorbital wrinkles, according to a study published in the November issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Genuine Very Large Effects in Trials Rare in Medicine

TUESDAY, Oct. 23 (HealthDay News) -- Large treatment effects are most likely to be found in small studies, with the effect diminishing with additional trials, according to research published in the Oct. 24 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

TNF Inhibitor Use Doesn't Up Short-Term Cancer Incidence

MONDAY, Oct. 22 (HealthDay News) -- Treatment of chronic immune-mediated diseases with tumor necrosis factor (TNF) inhibitors does not result in any short-term increase in cancer incidence, compared with other commonly used therapies for these conditions, according to a study published online Oct. 10 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Return to Work Difficult for Doctors on Sick Leave

THURSDAY, Oct. 18 (HealthDay News) -- Returning to work after a prolonged sick leave for physical or mental health problems, or drug or alcohol problems, is difficult for doctors, who describe self-stigmatization and fear a negative response on their return to work, according to a study published online Oct. 15 in BMJ Open.

Abstract
Full Text (subscription or payment may be required)

Delays in Diagnosis, Variations in Treatment for Morphea

WEDNESDAY, Oct. 17 (HealthDay News) -- Patients with localized scleroderma (morphea) often experience delay in diagnosis and variability in treatment that is based more on the specialty of the provider than disease characteristics, according to a study published in the November issue of the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Filaggrin Mutations Up Risk of Irritant Contact Dermatitis

FRIDAY, Oct. 12 (HealthDay News) -- Both atopic dermatitis (AD) and loss-of-function mutations in the filaggrin gene (FLG) are independently associated with an increased risk of developing chronic irritant contact dermatitis (ICD), with people having both mutations at about a five-fold higher risk, according to research published online Oct. 5 in the British Journal of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Leflunomide Considered Safe, Effective for Psoriatic Arthritis

FRIDAY, Oct. 12 (HealthDay News) -- Leflunomide is effective for the treatment of patients with psoriatic arthritis (PsA) in daily clinical practice, according to a study published online Oct. 6 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Rapidly Progressive Alopecia Shows Favorable Prognosis

TUESDAY, Oct. 9 (HealthDay News) -- Patients with rapidly progressive alopecia areata (RPAA) tend to show favorable prognosis regardless of treatment selected, according to research published online Sept. 24 in the Journal of the American Academy of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Large Review Confirms Melanoma Risk Up in Immunosuppressed

TUESDAY, Oct. 9 (HealthDay News) -- Immunosuppressed patients, particularly solid-organ transplant recipients and lymphoma patients, have about a two-fold or higher risk of developing melanoma, according to research published in the October issue of the Mayo Clinic Proceedings.

Abstract
Full Text

Limiting the Problem of Missing Data Urged for Clinical Trials

WEDNESDAY, Oct. 3 (HealthDay News) -- Missing data compromise inferences from clinical trials, and due to the problematic nature of compensation with analysis methods, the importance of avoiding missing data in clinical trials is paramount, according to a special report published in the Oct. 4 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Meta-Analysis Confirms Sunbed, Non-Melanoma Skin Cancer Link

WEDNESDAY, Oct. 3 (HealthDay News) -- Pooled results of multiple studies confirm that indoor tanning increases the risk of non-melanoma skin cancers, especially if tanning starts before 25 years of age, according to research published online Oct. 2 in BMJ.

Full Text
Editorial (subscription or payment may be required)

Patients Benefit From Access to Physician Notes

MONDAY, Oct. 1 (HealthDay News) -- Patients report clinically relevant benefits and minimal concerns, while doctors do not experience negative consequences, from allowing patient access to visit notes, according to a study published in the Oct. 1 issue of the Annals of Internal Medicine.

Abstract
Full Text
Editorial

Copyright © 2012 ScoutNews, LLC. All rights reserved.


Previous: October 2012 Briefing - Cardiology Next: October 2012 Briefing - Diabetes & Endocrinology

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.